Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -1576.67% is 141% below its 5-year average of -655.07%, near the high end of its 5-year range (-8164.46%–0.00%).
272.60% below its 12-month average of -423.15%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -308.66%.
OPERATING MARGIN
-1576.67%
OPERATING MARGIN AVG TTM
-423.15%
OPERATING MARGIN AVG 3Y
-594.02%
OPERATING MARGIN AVG 5Y
-655.07%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-272.60%
CURRENT VS 3Y AVG
-165.42%
CURRENT VS 5Y AVG
-140.69%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 717 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Janux Therapeutics, Inc.
Market Cap
$1.05B
Operating Margin
-1576.67%
TTM Avg
-423.15%
3Y Avg
-594.02%
5Y Avg
-655.07%
Market Cap
$1.04B
Operating Margin
-8.99%
TTM Avg
-4.92%
3Y Avg
-23.48%
5Y Avg
-24.49%
Market Cap
$1.04B
Operating Margin
-377.11%
TTM Avg
-200.94%
3Y Avg
-143.24%
5Y Avg
-174.04%
Market Cap
$1.03B
Operating Margin
4.18%
TTM Avg
2.97%
3Y Avg
7.13%
5Y Avg
8.72%
Market Cap
$1.05B
Operating Margin
-6.98%
TTM Avg
-25.06%
3Y Avg
-156.73%
5Y Avg
-114.38%
Market Cap
$1.07B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-59.79%
Market Cap
$1.02B
Operating Margin
1.38%
TTM Avg
4.21%
3Y Avg
3.61%
5Y Avg
3.61%
Market Cap
$1.01B
Operating Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.00B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | $1.05B | -1576.67% | -423.15% | -594.02% | -655.07% |
| Castle Biosciences, Inc. (CSTL)vs › | $1.04B | -8.99% | -4.92% | -23.48% | -24.49% |
| Immatics N.V. (IMTX)vs › | $1.04B | -377.11% | -200.94% | -143.24% | -174.04% |
| Integra LifeSciences Holdings Corporation (IART)vs › | $1.03B | 4.18% | 2.97% | 7.13% | 8.72% |
| Teladoc Health, Inc. (TDOC)vs › | $1.05B | -6.98% | -25.06% | -156.73% | -114.38% |
| Cullinan Therapeutics, Inc. (CGEM)vs › | $1.07B | 0.00% | 0.00% | 0.00% | -59.79% |
| Lumexa Imaging Holdings, Inc. Common Stock (LMRI)vs › | $1.02B | 1.38% | 4.21% | 3.61% | 3.61% |
| Latigo Biotherapeutics Inc. (LTGO)vs › | $1.01B | N/A | N/A | N/A | N/A |
| LB Pharmaceuticals Inc Common Stock (LBRX)vs › | $1.00B | 0.00% | 0.00% | 0.00% | 0.00% |
| IRadimed Corporation (IRMD)vs › | $1.09B | 31.92% | 30.59% | 30.27% | 23.69% |
Gross Margin
79.7%
Operating Margin
-1576.7%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -308.66% |
| 2026-03-31 | -916.50% |
| 2025-12-31 | -538.08% |
| 2025-09-30 | -352.51% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | -8164.46% |
| 2024-06-30 | -155.36% |
| 2024-03-31 | -1610.30% |
| 2023-12-31 | -655.71% |
| 2023-09-30 | -628.25% |
| 2023-06-30 | -1962.91% |
| 2023-03-31 | -990.28% |
| 2022-12-31 | -642.04% |
| 2022-09-30 | -994.04% |
| 2022-06-30 | -729.85% |
| 2022-03-31 | -852.23% |
| 2021-12-31 | -834.78% |
| 2021-09-30 | -940.72% |
| 2021-06-30 | -1297.10% |
| 2021-03-31 | -601.05% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
